Usefulness of plasma galectin-3 levels in systolic heart failure to predict renal insufficiency and survival

American Journal of Cardiology

Volumn 108, Issue 3, 2011, Pages 385-390

  Tang, W H Wilson ^a   Shrestha, Kevin ^a   Shao, Zhili ^a   Borowski, Allen G ^a   Troughton, Richard W ^b   Thomas, James D ^a   Klein, Allan L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Christchurch School of Medicine   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GALECTIN 3; SPIRONOLACTONE;

ADULT; ARTICLE; CAUSE OF DEATH; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; GROUPS BY AGE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE RELAXATION; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL RATE; SYSTOLIC HEART FAILURE;

ADULT; AGE FACTORS; AGED; CHRONIC DISEASE; COHORT STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; GALECTIN 3; GLOMERULAR FILTRATION RATE; HEART FAILURE, SYSTOLIC; HEMODYNAMICS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REFERENCE VALUES; RENAL INSUFFICIENCY; SURVIVAL RATE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79960350455     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2011.03.056     Document Type: Article

References (22)

1. U.C. Sharma, S. Pokharel, T.J. van Brakel, J.H. van Berlo, J.P. Cleutjens, B. Schroen, S. André, H.J. Crijns, H.J. Gabius, J. Maessen, and Y.M. Pinto Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction Circulation 110 2004 3121 3128 (Pubitemid 39492008)
2. R.A. Thandavarayan, K. Watanabe, M. Ma, P.T. Veeraveedu, N. Gurusamy, S.S. Palaniyandi, S. Zhang, A.J. Muslin, M. Kodama, and Y. Aizawa 14-3-3 Protein regulates Ask1 signaling and protects against diabetic cardiomyopathy Biochem Pharmacol 75 2008 1797 1806
3. U. Sharma, N.E. Rhaleb, S. Pokharel, P. Harding, S. Rasoul, H. Peng, and O.A. Carretero Novel anti-inflammatory mechanisms of N-acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage Am J Physiol Heart Circ Physiol 294 2008 H1226 H1232
4. Y.H. Liu, M. D'Ambrosio, T.D. Liao, H. Peng, N.E. Rhaleb, U. Sharma, S. André, H.J. Gabius, and O.A. Carretero N-acetyl-seryl-aspartyl-lysyl- proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin Am J Physiol Heart Circ Physiol 296 2009 H404 H412
5. N.C. Henderson, A.C. Mackinnon, S.L. Farnworth, T. Kipari, C. Haslett, J.P. Iredale, F.T. Liu, J. Hughes, and T. Sethi Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis Am J Pathol 172 2008 288 298 (Pubitemid 351282017)
6. R.R. van Kimmenade, J.L. Januzzi Jr, P.T. Ellinor, U.C. Sharma, J.A. Bakker, A.F. Low, A. Martinez, H.J. Crijns, C.A. MacRae, P.P. Menheere, and Y.M. Pinto Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure J Am Coll Cardiol 48 2006 1217 1224 (Pubitemid 44345127)
7. M. Lainscak, A.P. Coletta, N. Sherwi, and J.G. Cleland Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE-HF, COACH galectin-3 substudy, HF-ACTION nuclear substudy, DAD-HF, and MARVEL-1 Eur J Heart Fail 12 2010 193 196
8. D.J. Lok, P. Van Der Meer, P.W. de la Porte, E. Lipsic, J. Van Wijngaarden, H.L. Hillege, and D.J. van Veldhuisen Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study Clin Res Cardiol 99 2010 323 328
9. Y.H. Lin, L.Y. Lin, Y.W. Wu, K.L. Chien, C.M. Lee, R.B. Hsu, C.L. Chao, S.S. Wang, Y.C. Hsein, L.C. Liao, Y.L. Ho, and M.F. Chen The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients Clin Chim Acta 409 2009 96 99
10. R.W. Troughton, D.L. Prior, J.J. Pereira, M. Martin, A. Fogarty, A. Morehead, T.G. Yandle, A.M. Richards, R.C. Starling, J.B. Young, J.D. Thomas, and A.L. Klein Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function J Am Coll Cardiol 43 2004 416 422 (Pubitemid 38167702)
11. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 1999 461 470 (Pubitemid 29135798)
12. R.W. Troughton, D.L. Prior, C.M. Frampton, P.J. Nash, J.J. Pereira, M. Martin, A. Fogarty, A.J. Morehead, R.C. Starling, J.B. Young, J.D. Thomas, M.S. Lauer, and A.L. Klein Usefulness of tissue Doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT study) Am J Cardiol 96 2005 257 262 (Pubitemid 40978585)
13. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, J.S. Shanewise, S.D. Solomon, K.T. Spencer, M.S. Sutton, and W.J. Stewart Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463 (Pubitemid 41821197)
14. W.H. Tang, F. Van Lente, K. Shrestha, R.W. Troughton, G.S. Francis, W. Tong, M.G. Martin, A.G. Borowski, S. Jasper, R.C. Starling, and A.L. Klein Impact of myocardial function on cystatin C measurements in chronic systolic heart failure J Card Fail 14 2008 394 399 (Pubitemid 351749833)
15. N.C. Henderson, A.C. Mackinnon, S.L. Farnworth, F. Poirier, F.P. Russo, J.P. Iredale, C. Haslett, K.J. Simpson, and T. Sethi Galectin-3 regulates myofibroblast activation and hepatic fibrosis Proc Natl Acad Sci U S A 103 2006 5060 5065
16. R.V. Shah, A.A. Chen-Tournoux, M.H. Picard, R.R. van Kimmenade, and J.L. Januzzi Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure Eur J Heart Fail 12 2010 826 832
17. R.A. de Boer, D.J. Lok, T. Jaarsma, P. van der Meer, A.A. Voors, H.L. Hillege, and D.J. van Veldhuisen Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction Ann Med 43 2011 60 68
18. S. Sasaki, Q. Bao, and R.C. Hughes Galectin-3 modulates rat mesangial cell proliferation and matrix synthesis during experimental glomerulonephritis induced by anti-Thy1.1 antibodies J Pathol 187 1999 481 489 (Pubitemid 29118282)
19. X.W. Cheng, K. Obata, M. Kuzuya, H. Izawa, K. Nakamura, E. Asai, T. Nagasaka, M. Saka, T. Kimata, A. Noda, K. Nagata, H. Jin, G.P. Shi, A. Iguchi, T. Murohara, and M. Yokota Elastolytic cathepsin induction/activation system exists in myocardium and is upregulated in hypertensive heart failure Hypertension 48 2006 979 987 (Pubitemid 44611013)
20. F. Sam, and D.A. Siwik Digesting the remodeled heart: role of lysosomal cysteine proteases in heart failure Hypertension 48 2006 830 831 (Pubitemid 44610992)
21. J.H. Ix, M.G. Shlipak, G.M. Chertow, S. Ali, N.B. Schiller, and M.A. Whooley Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study J Card Fail 12 2006 601 607 (Pubitemid 44512149)
22. P.C. Patel, C.R. Ayers, S.A. Murphy, R. Peshock, A. Khera, J.A. de Lemos, J.A. Balko, S. Gupta, P.P. Mammen, M.H. Drazner, and D.W. Markham Association of cystatin C with left ventricular structure and function: the Dallas Heart Study Circ Heart Fail 2 2009 98 104